Merck & Co Inc (NYSE:MRK) does about 8.43M shares in volume on a normal day but saw 6787997 shares change hands in Monday trading. The company now has a market cap of 329.55B USD. Its current market price is $130.12, marking a decrease of -0.82% compared to the previous close of $131.20. The 52 week high reached by this stock is $133.10 whilst the lowest price level in 52 weeks is $99.14.
Merck & Co Inc (MRK) has a 20-day trading average at $127.42 and the current price is -2.24% off the 52-week high compared with 31.25% distance from its 52-week low. The 50-day simple moving average of the closing price is $126.37 and its 200-day simple moving average is $113.23. If we look at the stock’s price movements over the week, volatility stands at 1.92%, which decreases to 1.58% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 62.98 to suggest the stock is neutral.
The consensus objective for the share price is $141.63, suggesting that the stock has a potential upside of 8.13% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 11, 2024 when Societe Generale downgraded the stock to “Sell” and issued a price target of $104. TD Cowen upgraded the stock to “Outperform” from Market Perform on January 04, 2024 at a price target of $125-$135. Deutsche Bank initiated its price target at $115.
Merck & Co Inc (MRK) stock is up 2.51% over the week and -1.39% over the past month. Its price is 19.35% year-to-date and 12.99% over the past year.
To reach the target analysts have set, the stock logically needs to grow 8.13 percent from here.
The company has a return on investment of 3.19% and return on equity of 0.87%. The price to earnings ratio (P/E ratio) amounts to 144.85 while the forward price to earnings ratio is 13.20. The beta has a value of 0.40. Price to book ratio is 8.77 and price to sales ratio is 5.40.
